Albumin binding comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-11. Numbers and descriptions here follow the published literature rather than marketing material.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Chain length | 29 amino acids | Based on the GRF(1-29) fragment |
| Appearance | White to off-white lyophilized powder | Common research supply form |
| Solubility | Soluble in water and aqueous buffers | Powder requires reconstitution before use |
| Typical storage | −20 °C or below | Kept away from light and moisture |
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
Purity is most often assessed by reversed-phase high-performance liquid chromatography, reported as a percentage of total peak area. Identity is confirmed by mass spectrometry, which yields a molecular ion consistent with the expected sequence. Amino acid analysis and peptide mapping provide additional characterization. Reported purity values are method-dependent, so figures from different laboratories are not always directly comparable without details of column, gradient, and detection wavelength.
=== True cobras === The cobras (Naja spp.) are a medically important group of snakes due to the number of bites and fatalities they cause across their geographical range. The genus Naja consists of 20 to 22 species, but has undergone several taxonomic revisions in recent years, so sources vary greatly. They range throughout Africa (including some parts of the Sahara where Naja haje can be found), Southwest Asia, Central Asia, South Asia, East Asia, and Southeast Asia. The most recent revision, listed 28 species after the synonymisation of Boulengerina and Paranaja with Naja. But unlike some other members of the family Elapidae (the species of the genus Bungarus, genus Oxyuranus, genus Pseudohaje, and especially genus Dendroaspis), half of the bites by many species of both African and Asian origin of the genus Naja are "dry bites" (a dry bite is a bite by a venomous snake in which no venom is released). Roughly 45–50% of bites by most cobra species are dry bites and thus don't cause envenomation. Some of the species that are known and documented to deliver dry bites in a majority of cases include Naja naja, Naja kaouthia, Naja sputatrix, Naja siamensis, Naja haje, Naja annulifera, Naja anchietae, and Naja nigricollis. Some species will inject venom in the majority of their bites, but still deliver high number of dry bites (40–45%) include: Naja sumatrana, Naja melanoleuca, Naja atra, Naja mossambica and Naja katiensis. Within this genus, there are a few species in which dry bites are very rare. Envenoming occurs in at least 75–80% of bite cases involving these species.
Biography at the Biographical Directory of the United States Congress Financial information (federal office) at the Federal Election Commission Legislation sponsored at the Library of Congress Profile at Vote Smart Campaign contributions at OpenSecrets.org Follow the Money – John Kennedy 2007 2005 2003 1999 Louisiana Treasurer campaign contributions
Chondrocytes will proliferate too quickly and disrupt the assembly at the cartilage anlage and detrimentally alter the formation of bone. This mutation acts in a dosage fashion, meaning that when only one copy is present, there is still an uptake in FGF expression, but less so than when there are two copies of the mutation.
== Selected bibliography == Gitashri Naiya, Paromita Raha, Manas Mondal, Uttam Pal, Rajesh Saha, Susobhan Choudhury, Subrata Batabyal, Samir Kumar Pal, Dhananjay Bhattacharyya, Nakul Chandra Maiti, Siddhartha Roy (June 2016). "Conformational Selection Underpins Recognition of Multiple DNA sequences by Proteins and Consequent Functional Actions". Physical Chemistry Chemical Physics. 18 (31): 21618–21628. Bibcode:2016PCCP...1821618N. doi:10.1039/C6CP03278H. PMID 27426617.{{cite journal}}: CS1 maint: multiple names: authors list (link) Samir Kumar Pal, Susobhan Choudhury, Basusree Ghosh, Priya Singh, Raka Ghosh, Siddhartha Roy (June 2016). "Ultrafast Differential Flexibility of Cro-protein Binding Domains of Two Operator DNAs with Different Sequences". Physical Chemistry Chemical Physics. 18 (27): 17983–17990. Bibcode:2016PCCP...1817983C. doi:10.1039/C6CP02522F. PMID 27326896.{{cite journal}}: CS1 maint: multiple names: authors list (link) Sk Kayum Alam, Vinod Yadav, Swati Bajaj, Arindam Datta, Shamit Kumar Dutta, Madhumita Bhattacharyya, Santanu Bhattacharya, Subrata Debnath, Siddhartha Roy, Lisa A Boardman, Thomas Smyrk, Julian R. Molina, Saikat Chakrabarty, Shantanu Chowdhury, Debabrata Mukhopadhyay, Susanta Roychoudhury (April 2016). "DNA Damage-Induced Ephrin-B2 Reverse Signaling Promotes Chemoresistance and Drives EMT in Colorectal Carcinoma Harboring Mutant p53". Cell Death and Differentiation. 23 (4): 707–722. doi:10.1038/cdd.2015.133. PMC 4986638.
Sources: en.wikipedia.org
While some EU member states have privatised all, and some part, of their telecomms infrastructure, publicly or community-owned internet providers (such as in Denmark or Romania) tend to have the fastest web speeds.
==== Minimum wage and income tax reforms ==== On 16 February, Lula increased the value of the minimum wage from 1,302 reals to 1,320 reals, correcting it above inflation. In December, there was another increase on the minimum wage, going from 1,320 to 1,412 reals, the increase became effective on 1 January 2024. According to Lula, these actions are the result of a new "minimum wage valorization" project idealized by him, which will adjust the minimum wage over inflation every year, as a way to keep up with the price changes for basic products. In early 2023, there was also an increase in the exemption from Income tax to 2,640 reals, compared to the previous amount of 1,900 reals. In February 2024, continuing the increase in income tax exemption, Lula issued a provisional measure that exempts those who receive up to 2,824 reais from payment (equivalent to two minimum wages per month).
== External links == Controlled vocabulary of post-translational modifications in Uniprot List of posttranslational modifications in ExPASy Browse SCOP domains by PTM — from the dcGO database Overview and description of commonly used post-translational modification detection techniques
Sources: en.wikipedia.org
After a diplomatic crisis started between Venezuela and Guyana (both Brazilian neighbours) in October 2023, President Lula tried to mediate a de-escalation while stating that "we do not want and we do not need a war in South America". Officials from Brazil, along with those from the CARICOM, Colombia, the United Nations and the CELAC attended a meeting between Venezuelan and Guyanese presidents in December 2023 to ease tensions between the nations. Brazil offered to host further talks to promote peace in the region, which was agreed by the two countries, and a meeting between Venezuelan and Guyanese Foreign Ministers took place on 25 January 2024, with both parties pledging to keep the peace and hold further talks.
The Journal of Pharmacy Practice is a bimonthly peer-reviewed healthcare journal that covers the field of pharmacy, including new drugs and therapies, pharmacokinetics, drug administration, and adverse drug reactions. The editor-in-chief is Michael Liu (Touro College of Pharmacy). It was established in 1988 and is currently published by SAGE Publications.
In this process, uranium hexafluoride is repeatedly diffused through a silver-zinc membrane, and the different isotopes of uranium are separated by diffusion rate (since uranium-238 is heavier it diffuses slightly slower than uranium-235). The molecular laser isotope separation method employs a laser beam of precise energy to sever the bond between uranium-235 and fluorine. This leaves uranium-238 bonded to fluorine and allows uranium-235 metal to precipitate from the solution. An alternative laser method of enrichment is known as atomic vapor laser isotope separation (AVLIS) and employs visible tunable lasers such as dye lasers. Another method used is liquid thermal diffusion. The only significant deviation from the 235U to 238U ratio in any known natural samples occurs in Oklo, Gabon, where natural nuclear fission reactors consumed some of the 235U some two billion years ago when the ratio of 235U to 238U was more akin to that of low enriched uranium allowing regular ("light") water to act as a neutron moderator akin to the process in humanmade light water reactors. The existence of such natural fission reactors which had been theoretically predicted beforehand was proven as the slight deviation of 235U concentration from the expected values were discovered during uranium enrichment in France.
Sources: en.wikipedia.org
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.
DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.
Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.
It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.